These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3505198)

  • 41. Effects of calcitonin on metabolically-induced bone changes in rats.
    Clark MB; Pennock J; Kalu DN; Bordier P; Doyle FH; Foster GV
    Calcif Tissue Res; 1968; ():Suppl:18. PubMed ID: 5721053
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Human calcitonin, serum-phosphate, renal failure.
    McGeown MG
    Lancet; 1974 Apr; 1(7861):813-4. PubMed ID: 4132751
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter: Human calcitonin and serum-phosphate.
    Silva OL; Becker KL; Selawry HP; Snider RH; Moore CF; Bivins LE; Shalhoub RJ
    Lancet; 1974 May; 1(7865):1055. PubMed ID: 4133736
    [No Abstract]   [Full Text] [Related]  

  • 44. The biochemical and histological analysis of subcutaneous calcitonin and intramedullary methylprednisolone on bone repair after bone marrow ablation: an experimental comparative study in rats.
    Ersozlu S; Sarisozen B; Ozer O; Adim SB; Sahin O
    J Exp Orthop; 2017 Dec; 4(1):25. PubMed ID: 28730582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High serum calcitonin levels in heroin addicts.
    Tagliaro F; Capra F; Dorizzi R; Luisetto G; Accordini A; Renda E; Parolin A
    J Endocrinol Invest; 1984 Aug; 7(4):331-3. PubMed ID: 6501805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: Human calcitonin, serum-phosphate, renal failure.
    Szücs J
    Lancet; 1974 Jun; 1(7866):1108. PubMed ID: 4135266
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of experimental bone atrophy by thyrocalcitonin.
    Fujita T; Orimo H; Ohata M; Nakanishi K; Yoshikawa M; Misaka E
    Endocrinol Jpn; 1968 Mar; 15(1):8-12. PubMed ID: 5695570
    [No Abstract]   [Full Text] [Related]  

  • 48. Failure of calcitonin to prevent disuse osteopenia: An experimental study in rabbits.
    Singh M; Jowsey J
    Endocrinology; 1970 Jul; 87(1):183-6. PubMed ID: 4987299
    [No Abstract]   [Full Text] [Related]  

  • 49. Juvenile hypocalcemia provokes persistent electroencephalographic change in renally compromised rats.
    Lipman JJ; White DL; Lawrence PL; Teschan PE
    J Am Coll Nutr; 1988 Dec; 7(6):453-60. PubMed ID: 3230233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Demonstration of the action of porcine calcitonin on bone of the trout Salmo gairdnerii subjected to a demineralizing treatment].
    Lopez E; Chartier-Baraduc MM; Deville J
    C R Acad Hebd Seances Acad Sci D; 1971 May; 272(20):2600-3. PubMed ID: 4997895
    [No Abstract]   [Full Text] [Related]  

  • 51. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
    Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
    Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of calcium-regulating-hormone on BMC in patients with CRF.
    Lü YM; Xiao HW; Liang KH
    J Tongji Med Univ; 1995; 15(2):95-7. PubMed ID: 8731961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N; Miyata S; Obana S; Kobayashi N; Fukushima N; Burke SK; Wada M
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the control of phosphate in the progression of chronic renal failure.
    Barrientos A; Arteaga J; Rodicio JL; Alvarez Ude F; Alcazar JM; Ruilope LM
    Miner Electrolyte Metab; 1982 Mar; 7(3):127-33. PubMed ID: 7169978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of phosphate in the potentiation or amelioration of acute renal failure.
    Dobyan DC; Bulger RE; Eknoyan G
    Miner Electrolyte Metab; 1991; 17(2):112-5. PubMed ID: 1753919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exogenous calcitonin protects against renal bone disease in rats with early renal failure.
    D'Angelo A; Bonucci E; Giannini S; Benetollo P; Lodetti MG; Castrignano R; Malvasi L; Maschio G
    Bone Miner; 1987 Nov; 3(2):171-6. PubMed ID: 3505198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.